Nitric Oxide in Glaucoma: What You Need to Know

1.00 CME
$0 FEE
Nitric Oxide in Glaucoma: What You Need to Know


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

This activity is supported by an educational grant from Bausch + Lomb.  

Activity Description

Glaucoma continues to be a leading cause of blindness worldwide with many patients at risk for disease progression due to inadequate control of intraocular pressure (IOP). Evaluation of nitric oxide signaling has demonstrated that it plays a key role in IOP regulation via its action on the conventional outflow pathway. These findings have led to the development of nitric oxide–donating agents that have the potential to produce significant improvements in IOP control. In this live educational symposium, experts in the field will review the role of the nitric oxide pathway in the regulation of IOP, as well as evaluate new evidence regarding the safety and efficacy of nitric oxide–based therapies for the treatment of patients with glaucoma.

Target Audience

The intended audience for the activity is ophthalmologists and other health care professionals involved in the management of patients with glaucoma.

Learning Objective(s)

Upon successful completion of this activity, participants should be better able to:

  • Describe the role of nitric oxide in the regulation of intraocular pressure and as a therapeutic target in glaucoma management.
  • Summarize new evidence regarding the safety and efficacy of nitric oxide-based agents for the treatment of patients with glaucoma.


Thomas W. Samuelson, MD
Attending Surgeon
Glaucoma and Anterior Segment Surgery
Minnesota Eye Consultants, P.A.
Adjunct Professor of Ophthalmology
University of Minnesota
Minneapolis, MN


John P. Berdahl, MD
Refractive, Cataract, Glaucoma, and Corneal Surgeon
Vance Thompson Vision
Sioux Falls, SD

John R. Samples, MD
Clinical Professor
Elson S. Floyd College of Medicine
Washington State University
Spokane, WA
Western Glaucoma Foundation
Olympia, WA


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, February 11, 2020, through February 10, 2021.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Moderator and Faculty report the following relationship(s)

John P. Berdahl, MD
Royalty: Imprimis
Consulting Fee: Alcon, Allergan, Aurea Medical, Avedro, Bausch + Lomb, CorneaGen, Dakota Lions Eye Bank, Equinox, Expert Opinion, Glaukos, Gore, Imprimis, J&J Vision, Kala, Kedalion, Melt Pharmaceuticals, MicroOptx, New World Medical, Ocular Surgical Data, Ocular Therapeutix, Omega Ophthalmic, Orasis, Oyster Point, RxSight, Surface Inc., Tarsus, TearClear, ViaLase, Vittamed, Vance Thompson Vision, Visionary Ventures, Zeiss
Speakers Bureau: Alcon, Allergan, Glaukos
Ownership Interest: CorneaGen, Equinox, Expert Opinion, Ocular Surgical Data, Omega Ophthalmic, Surface, Vance Thompson Vision, Zeiss

John R. Samples, MD
Royalty: Kugler, Springer
Intellectual Property/Patent: ALeyeGN
Consulting Fee: ALeyeGN, Allergan
Speakers Bureau: Aerie, Novartis

Thomas W. Samuelson, MD
Consulting Fee: Abbott Medical Optics, AcuMems, Aerie, Akorn, Alcon, AqueSys/Allergan, Bausch + Lomb/Valeant, BELKIN Laser, Endo Optiks, Equinox, Glaukos, Ivantis, Ocular Surgery News, Ocuphire, PolyActiva, Santen, Shire, Sight Science, SLACK Inc, Transcend Medical, Veracity Innovations
Ownership Interest: BELKIN Laser, Equinox, Glaukos, Ivantis, Ocuphire, Sight Sciences, TearClear

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at